Latest News

SCHAUMBURG, Ill. (March 23, 2017) —

According to findings released at AAD’s 2017 Annual Meeting, crisaborole led to complete or near-complete clearance of atopic dermatitis within a month in 32.1 percent of adult and pediatric patients.

SCHAUMBURG, Ill. (March 14, 2017) —

According to a recent study published in Dermatologic Surgery, combining Jessner solution and trichloroacetic acid may be a more effective treatment for melasma in dark-skinned patients than trichloroacetic acid alone.

Orlando, Fla., (March 5, 2017)

MACRAAsk an expert

AAD has launched an online discussion forum allowing members to ask expert staff questions about MACRA. Members also are encouraged to share their experiences and knowledge with their colleagues.

Learn more
Prior authorizationsCreate a patient letter

Need a quick way to create a prior authorization patient letter? Complete the following steps to create an individualized letter appealing a denial for a prescribed treatment for your patient.       

learn more
TeledermatologyFundamentals of Teledermatology

Complete the AAD's newest online course, The Fundamentals of Teledermatology, and earn three CMEs. Search "Telederm" in the Online Learning Center.

learn more
New appDermWorld app

Easily access the latest issues of Dermatology World, DW Weekly, and the DW blog on iOS and Android. The app includes a robust search function so that you can quickly find the content you need.

learn more

For Public & Patients

Expert insights into the care and treatment of your skin, hair, and nails for a lifetime of healthy habits.


Sign-up to receive our free monthly public education e-newsletter which provides skin-care tips from leading dermatologists. Sign-up today!

2017 Summer Academy Meeting
July 27-30, 2017
New York

Connect with your colleagues, take part in engaging sessions on trending topics, and bring the latest in dermatology care back to your patients – all during the 2017 Summer Academy Meeting! Join us in New York and experience the best of dermatology.

Learn more

Latest Publications

A full plate of policy: How will the new government affect dermatology's issues?

Spotlight on photodermatoses: Pruritic, mostly rare disorders can pose diagnostic challenge

How does your garden grow? Strategies for evaluating staff performance  

March 2017

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis

Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis
2017 Annual Meeting
AAD Meeting News

  • Sulzberger lecturer links psoriasis, CV disease

  • Quality teledermatology is part of the future for dermatology

  • Gruber lecturer discusses role of UV radiation in mole mutations

  • Avoid these mistakes for a blemish-free resume

  • Boards' Fodder: Photosensitivity Disorders

  • Career case study: The life of  a Mohs specialist

Winter 2016

Take the first step to reduce skin cancer

AAD and me

Striking the right chord